. P2X receptor-mediated ionic currents in dorsal root ganglion neurons. J. Neurophysiol. 82: 1590Neurophysiol. 82: -1598Neurophysiol. 82: , 1999. Nociceptive neurons in the dorsal root ganglia (DRG) are activated by extracellular ATP, implicating P2X receptors as potential mediators of painful stimuli. However, the P2X receptor subtype(s) underlying this activity remain in question. Using electrophysiological techniques, the effects of P2X receptor agonists and antagonists were examined on acutely dissociated adult rat lumbar DRG neurons. Putative P2X-expressing nociceptors were identified by labeling neurons with the lectin IB4. These neurons could be grouped into three categories based on response kinetics to extracellularly applied ATP. Some DRG responses (slow DRG) were relatively slowly activating, nondesensitizing, and activated by the ATP analogue ␣,␤-meATP. These responses resembled those recorded from 1321N1 cells expressing recombinant heteromultimeric rat P2X 2/3 receptors. Other responses (fast DRG) were rapidly activating and desensitized almost completely during agonist application. These responses had properties similar to those recorded from 1321N1 cells expressing recombinant rat P2X 3 receptors. A third group (mixed DRG) activated and desensitized rapidly (P2X 3 -like), but also had a slow, nondesensitizing component that functionally prolonged the current. Like the fast component, the slow component was activated by both ATP and ␣,␤-meATP and was blocked by the P2X antagonist TNP-ATP. But unlike the fast component, the slow component could follow highfrequency activation by agonist, and its amplitude was potentiated under acidic conditions. These characteristics most closely resemble those of rat P2X 2/3 receptors. These data suggest that there are at least two populations of P2X receptors present on adult DRG nociceptive neurons, P2X 3 and P2X 2/3 . These receptors are expressed either separately or together on individual neurons and may play a role in the processing of nociceptive information from the periphery to the spinal cord.
I N T R O D U C T I O N
The dorsal root ganglion (DRG) contains the cell bodies of primary afferent sensory neurons that relay nociceptive and proprioceptive information from the periphery to the dorsal horn of the spinal cord. Pharmacological modulation of neurotransmitter receptors involved in the propagation of pain signals via the DRG should therefore shift the threshold for nociception. In this context, P2X receptors located on peripheral sensory neurons have been implicated in the initiation of pain (Bland-Ward and Humphrey 1997; Burnstock 1996; Cook et al. 1997) . However, the P2X receptor subtypes underlying this phenomenon have not been elucidated, nor has their subcellular localization or activation characteristics.
P2X receptors belong to a family of ligand-gated ion channels that are activated by extracellular ATP (Ralevic and Burnstock 1998) . Seven distinct P2X receptors (P2X 1 -P2X 7 ) have been identified and cloned, and six of these (P2X 1 -P2X 6 ) may be expressed on the plasma membrane of neurons (Collo et al. 1996 ; Lewis et al. 1995; Valera et al. 1994) . Within the rat peripheral nervous system, localization of P2X 3 message was initially described in neurons of the DRG (Chen et al. 1995; Lewis et al. 1995) . Although mRNA for other P2X receptors is present in these neurons, colocalization of both P2X 2 and P2X 3 receptor protein has been demonstrated in a subset of DRG neurons . In rat nodose ganglia, coexpressed P2X 2 and P2X 3 receptor subtypes form functional heteromultimeric P2X 2/3 receptors (Radford et al. 1997 ; Thomas et al. 1998) . From these data, it is clear that native P2X receptors can exist as either hetero-or homomultimeric complexes in sensory neurons.
Rat DRG are comprised of a variety of neuronal cell types that differ in their intrinsic electrophysiological (Caffrey et al. 1992; Harper and Lawson 1985b; Scroggs and Fox 1992; Scroggs et al. 1994 ) and cytochemical (Dodd et al. 1984; Schoenen et al. 1989) properties. Among these, nociceptive C-fiber neurons belong to a subset of small diameter cells located in the DRG (Harper and Lawson 1985a) . The isolectin IB4 has been shown to selectively label small-diameter DRG nociceptors that are largely TrkA negative and nonpeptidergic (Molliver et al. 1995) . IB4-positive neurons also express the P2X 3 receptor (Vulchanova et al. 1998) , and expression patterns suggest that it is colocalized with the P2X 2 receptor in some DRG neurons . A subset of capsaicin-sensitive, peripherin-positive C-fiber neurons also contains P2X 3 receptor mRNA (Chen et al. 1995) . Taken together, it appears that P2X 3 receptors are expressed primarily on nociceptive DRG neurons.
It is known that P2X 2 and P2X 3 receptors are expressed on the surface of rat DRG neurons, but it is not known in what proportions functional homomeric P2X 2 , P2X 3 , or heteromeric P2X 2/3 receptors are expressed. Rapidly desensitizing ATP-or ␣,␤-methylene ATP-evoked responses have been described in neonatal rat DRG (Jahr and Jessell 1983; Rae et al. 1998; Robertson et al. 1996) . Although these response properties fit those for either P2X 1 or P2X 3 receptors, the pharmacological profile of rat DRG responses suggests that the rapidly desensitizing response is mediated by P2X 3 , and not P2X 1 receptors (Rae et al. 1998) . However, there appear to be some species differences with respect to P2X receptor expression in DRG (Bean 1990) . Rat DRG response properties resemble those of P2X 3 receptors (Chen et al. 1995) , whereas the nondesensitizing properties of bullfrog DRG neurons (Bean 1990; Li et al. 1993 ) resemble P2X 2 or P2X 2/3 receptor activation (Brake et al. 1994; Lewis et al. 1995) .
Many behavioral studies concerning the function of primary afferent neurons in various pain models are conducted in the adult rat. Because of possible species differences, potential developmental changes, or influences of long-term culture conditions on P2X receptor expression, the present study was designed to characterize P2X responses in acutely dissociated adult rat DRG neurons. Based on pharmacological and kinetic profiles, the data presented here support the existence of at least two distinct P2X receptor subtypes in adult DRG neurons, P2X 3 and P2X 2/3 . Preliminary results from these studies have appeared in abstract form (Burgard et al. 1998) .
M E T H O D S

Neuronal cultures
Adult male Sprague-Dawley rats (ϳ8 wk old, 250 -300 g) were deeply anesthetized with CO 2 anesthesia and killed by decapitation. Lumbar (L 4 -L 6 ) DRG were dissected from the vertebral column and placed in Dulbecco's modified Eagles medium (DMEM, Hyclone, Logan, UT) containing 0.3% collagenase B (Boehringer Mannheim, Indianapolis, IN) for 60 min at 37°C. The collagenase was replaced with 0.25% trypsin (GIBCO-BRL, Grand Island, NY) in Ca 2ϩ /Mg 2ϩ -free Dulbecco's phosphate-buffered saline, and further digested for 30 min at 37°C. After washing in fresh DMEM, ganglia were dissociated by trituration using a fire-polished Pasteur pipette. Cells were washed in fresh DMEM and triturated again using a smaller bore fire-polished pipette to obtain a single-cell suspension. DRG cells were then plated on polyethelenimine (PEI)-treated 12 mm glass coverslips. Cells were plated at a density of one DRG per coverslip in 1 ml DMEM supplemented with 10% FBS (Hyclone), NGF (50 ng/ml, Boehringer Mannheim), and 100 U/ml Pen/Strep. Experimental procedures involving rats were conducted under a protocol approved by an Institutional Animal Care and Use Committee.
To label cutaneous afferent neurons, the fluorescent carbocyanine dye fast DiI (DiI, Molecular Probes, Eugene, OR) was injected into the subplantar hindpaw region of 7-to 8-wk-old rats. Injections of 50 l of a 20-mM solution in DMSO were administered 10 -12 days before culture preparation. Labeled neurons were identified in vitro using fluorescence optics.
Neurons were used for electrophysiological recording within 4 -48 h. In most experiments, the FITC-labeled plant lectin BSI-B 4 (IB4, 10 g/ml) was added to the culture medium at 37°C for 5 min before recording. The coverslip was then washed with extracellular recording solution for 1 min before being placed in the recording chamber, which was mounted on the stage of an Olympus IX70 microscope equipped with fluorescence optics. Digital images were captured using a SPOT-2 camera system (Diagnostic Instruments, Sterling Hts, MI).
Cloning and expression of recombinant rat P2X receptors
Primers were designed to regions encompassing the initiation and termination codons of the rat P2X 2 and P2X 3 cDNAs (Genbank accession numbers; P2X 2 , U14114; P2X 3 , X90651). A consensus Kozak sequence was designed into the 5Ј primer of each primer pair to facilitate optimal translation efficiency (Kozak 1984) .
To clone the rat P2X 2 receptor, 100 ng of poly Aϩ RNA derived from rat total brain tissue (Clontech, Palo Alto, CA) was used in a first-strand cDNA synthesis reaction using Superscript II reverse transcriptase and reagents from GIBCO BRL. One-tenth of the reaction was used in a 50-l amplification reaction with 10 picomoles of each of the P2X 2 primers (sense P2X 2 , 5ЈCACCATGGTCCGGCG-CTTGGCCCGGGGC3Ј; antisense P2X 2 , 5ЈTCAAAGTTGGGCCA-AACCTTTGGGGTCCG3Ј). Additional components of the reaction included 200 M dNTPs, 1 ϫ Pfu buffer (Stratagene, La Jolla, CA). The reaction was incubated at 94°C for 1 min, then 80°C for 2 min during which 1.25 units Pfu polymerase (Stratagene) was added. The reaction was then cycled 35 times in a Perkin Elmer Model 9600 thermocycler (Perkin Elmer, Foster City, CA) under the following conditions: 94°C for 20 s, 65°C for 20 s, and 72°C for 4 min. Reaction products were separated by agarose gel electrophoresis; the major product of ϳ1.5 kilobases was isolated and cloned into the pCRscript vector (Stratagene) according to the manufacturer's instructions. The insert was sequenced by dye-terminator chemistry on a Perkin Elmer Model 310 genetic analyzer and found to be identical to the published sequence for the rat P2X 2 message (Brake et al. 1994) . The cDNA was excised from the vector by digestion with the restriction enzymes Bam HI and Not I and ligated into the vector pIRES(hyg) vector (Clontech).
The P2X 3 receptor cDNA was cloned from rat brain poly Aϩ RNA essentially as described above. The primers used in the PCR amplification reaction were as follows: sense P2X 3 , 5ЈTTCTCACCATG AACTGTATATCAGACTTCTTC3Ј; antisense P2X 3 , 5ЈAAGAGGC CCTAGTGACCAATAGAATAGGCCCC3Ј. Amplitaq thermopolymerase and buffers (Perkin Elmer) were used in this amplification. The reaction was cycled 35 times under the following conditions; 95°C for 30 s, 55°C for 30 s, and 72°C for 2 min. The major product of 1.3 kilobases was cloned into the vector pCRII (Invitrogen, Carlsbad, CA) as per manufacturer's instructions. The insert was sequenced and found to be identical to the published rat P2X 3 message (Chen et al. 1995) . The cDNA was excised from the vector and ligated into the vector pIRES(neo) vector (Clontech).
Expression plasmids encoding rat P2X 2 and P2X 3 receptor cDNAs were transfected individually into 1321N1 human astrocytoma cells using Lipofectamine (GIBCO BRL). After transfection (48 h), cells were subcultured in growth medium containing 800 g ml Ϫ1 G418 (rP2X 3 ) or 100 g ml Ϫ1 hygromycin (rP2X 2 ). Surviving individual colonies were isolated, screened for P2 receptor activity using a fluorescence-based calcium imaging assay, and selected for further characterization. The cell line expressing heteromeric rP2X 2/3 receptors was constructed by transfection of the rP2X 3 cDNA into rP2X 2 -expressing 1321N1 cells. Positive clones were isolated in growth medium containing 150 g ml Ϫ1 G418 and 75 g ml Ϫ1 hygromycin and selected based on their sensitivity to ␣,␤-meATP.
Cells expressing recombinant homomeric P2X 3 receptors were maintained at 37°C in DMEM (with 4.5 mg ml Ϫ1 glucose and 4 mM L-glutamine), 10% FBS and 300 g ml Ϫ1 G418 or 100 g ml
Ϫ1
hygromycin in a humidified 5% CO 2 atmosphere. Cells expressing rP2X 2/3 receptors were maintained in growth medium containing 150 g ml Ϫ1 G418 and 75 g ml Ϫ1 hygromycin. Cells were plated onto PEI-treated glass coverslips and used for recording at ϳ50% confluency.
Electrophysiology
Whole cell patch-clamp recordings were obtained from both DRG neurons and stably transfected 1321N1 cells. Cells were maintained in an extracellular recording solution (pH 7.4, 325 mosM) consisting of (in mM) 155 NaCl, 5 KCl, 2 CaCl 2 , 1 MgCl 2 , 10 HEPES, and 12 glucose. Patch electrodes were pulled from borosilicate glass and fire polished to 3-10 M⍀ tip resistance. Two internal pipette solutions (pH 7.3, 295 mosM) were used for recording. The first was used for the majority of recordings, and consisted of (in mM) 140 K-aspartate, 20 NaCl, 10 EGTA, and 5 HEPES. The second consisted of (in mM) 135 Cs-acetate, 10 CsCl, 0.5 EGTA, and 10 HEPES. No differences in P2X responses were observed when using either intracellular solution. Cells were typically voltage clamped at Ϫ60 mV, and series resistance was compensated 90 -95%. Currents were recorded using an Axopatch 200B amplifier (Axon Instruments, Foster City, CA) and digitized at 3 kHz for acquisition. For analysis, recordings were low-pass filtered at 1 kHz. Rise times of inward currents were measured between 10 and 90% peak. Exponential time constants of current desensitization () were estimated using a Chebyshev curvefitting algorithm. Most of the desensitizing currents in this study were best fitted by two exponential functions. For DRG neurons, resting membrane potential was measured immediately after rupture of the cell membrane in whole-cell patch mode. Neuronal input resistance was determined from the amplitude of the current response to a 10-mV hyperpolarizing pulse from a holding potential of Ϫ60 mV. A series of depolarizing voltage steps was applied to all neurons to determine the threshold for activation of a fast sodium current presumed to reflect firing of the action potential. For all cell types, baseline responses were recorded for a minimum of 10 min to ensure that the kinetics of the response were stable. A wash out or recovery period usually followed pharmacological manipulation of the response. Responses that exhibited long-lasting or irreversible changes in kinetics during the experiment were considered unstable and were not used for analysis. All data acquisition and analysis was performed using pClamp software (Axon Instruments).
Cells were constantly perfused with extracellular solution at a rate of 0.5 ml/min in the recording chamber. Agonists were applied to individual cells using a piezoelectric-driven rapid application system (Burleigh Instruments, Fishers, NY). Extracellular solution perfused the cell from one barrel of a glass theta tube positioned 100 m away. Agonist solution perfused the other barrel, and was applied by rapidly moving the solution interface across the cell. The time constant for solution exchange across the entire cell was 20 ms. This was measured by recording from 1321N1 cells expressing a nondesensitizing P2X receptor (rP2X 2 ), eliciting a steady-state ATP (10 M) current at Ϫ60 mV, rapidly switching from a low (2 mM) to high (55 mM) potassium extracellular ATP (10 M) solution, and measuring the resulting current relaxation. This method gave a more realistic measure of total cell exchange time than measuring the exchange time across an open pipette tip. The pipette open tip solution exchange time was on the order of 1-2 ms and was checked after each cell recording to ensure proper agonist application. Agonist applications were 400 -800 ms in duration and were typically given every 2-4 min. When the effects of pH were studied, cells were maintained at pH 7.4, and agonist (at pH 6.6) was applied. In this study, the P2X agonists ATP and ␣,␤-methylene ATP (␣,␤-meATP), and antagonists suramin (RBI, Natick, MA) and trinitrophenyl-ATP (TNP-ATP, Molecular Probes, Eugene, OR) were used.
All reagents were purchased from Sigma Chemical (St. Louis, MO) unless otherwise noted. All data are expressed as means Ϯ SE.
R E S U L T S
Basic properties of DRG neurons
The FITC-labeled lectin IB4 was used in initial experiments as a live cell marker to identify putative P2X 3 receptor-expressing nociceptive neurons (Vulchanova et al. 1998) . Approximately 75% of all cultured DRG neurons were labeled by IB4 (Fig. 1) , and 90% of these neurons responded to ATP. Once it was determined that these labeled cells would routinely respond to ATP, some subsequent experiments were performed on untreated neurons. No differences in neuronal membrane properties or P2X receptor-mediated responses were observed between IB4-labeled cells and small-diameter cells in cultures that were not treated with IB4.
Small (25-30 m) neurons that were devoid of neurite extension had resting membrane potentials of Ϫ52 Ϯ 3 (SE) mV and input resistances of 489 Ϯ 109 M⍀ (n ϭ 9). All neurons generated an inward sodium current following membrane depolarization to 0 mV (spike threshold Ϫ18 Ϯ 2 mV, n ϭ 9). A typical fast inward current was recorded with K-aspartate-filled pipettes. Intracellular Cs-acetate produced a widening of the inward current duration and an appearance of a prolonged plateau current resembling the prolonged action potential duration of small nociceptive DRG neurons (Harper and Lawson 1985b; McLean et al. 1988 ). Other membrane properties or ATP responses recorded with intracellular pipette solutions containing Cs-acetate were not significantly different from those recorded with K-aspartate-filled pipettes.
P2X responses in DRG neurons
Three general types of P2X responses were recorded from DRG neurons after ATP application. The first was a slow, nondesensitizing response characterized by relatively slow activation and no desensitization of current (slow DRG, Fig. 2A ). Current responses to 10 M ATP in six neurons showed relatively slow rise times (113 Ϯ 23 ms) to peak currents of 319 Ϯ 80 pA. Slow DRG currents were nondesensitizing, because 97 Ϯ 3% of peak current amplitude was still present at the end of ATP application. The second type of P2X response was fast, characterized by rapid current activation and fast desensitization (fast DRG, Fig. 3A) . Current responses to 10 M ATP in the fast DRG group (n ϭ 5) had fast rise times (10 Ϯ 2.0 ms) to peak currents of 536 Ϯ 186 pA. In the presence of agonist, current desensitization followed biexponential kinetics. An initial fast component ( 1 ϭ 32 Ϯ 2.7 ms) was followed by a smaller amplitude prolonged component ( 2 ϭ 339 Ϯ 64 ms). The currents desensitized almost completely, because there was only 5.8 Ϯ 2.1% of peak amplitude left as residual current at the end of agonist application. The third type of response was a mixed response (DRG-mixed, Fig. 3B ) that also exhibited both fast and slow desensitization kinetics, but the slow component was much more prominent than that seen in fast DRG responses. Current responses to 10 M ATP in this group (n ϭ 5) had relatively fast rise times (38 Ϯ 19 ms) to peak currents of 228 Ϯ 88 pA. Both fast ( 1 ϭ 25 Ϯ 2.0 ms) and slow ( 2 ϭ 424 Ϯ 173 ms) desensitizing components were observed, with residual currents at the end of agonist application measuring 38 Ϯ 4.8% of peak. Although the desensitization values were not different between fast and mixed DRG responses, mixed DRG responses had significantly larger residual slow component amplitudes than did fast DRG responses (P Ͻ 0.05, unpaired t-test). All three types of responses could be elicited by application of either ATP or the ATP analogue ␣,␤-meATP. The three types of responses were observed with approximately equal frequency.
Activation of P2X receptors by ATP in DRG neurons was verified by the use of the P2X receptor antagonists suramin and TNP-ATP. Suramin (10 M) produced a reversible inhibition of peak current to 48 Ϯ 27% of control (n ϭ 3) during coapplication with ATP (10 M, mixed DRG responses). Likewise, TNP-ATP (0.1 M), a P2X antagonist selective for P2X 3 , P2X 2/3 , and P2X 1 receptors , inhibited mixed DRG peak currents to 52 Ϯ 7% of control when coapplied with ATP (10 M, n ϭ 3). However, when TNP-ATP was preapplied for at least 30 s before ATP application, both fast and slow P2X currents were completely and reversibly blocked (n ϭ 3, Fig. 7B ). These results suggest that preapplication of antagonist is necessary for optimal antagonism, and that the receptor subtypes underlying DRG P2X responses are either P2X 3 , P2X 2/3 , or P2X 1 .
Comparison of DRG responses to recombinant rat P2X responses
Because DRG P2X responses could be grouped as either fast (desensitizing), slow (nondesensitizing), or mixed (fast and slow), the P2X receptor subtype(s) underlying each type of response were investigated. To do this, DRG responses were compared with responses from recombinant P2X receptors expressed in 1321N1 cells that lack endogenous expression of either P2X or P2Y receptors (Schachter and Harden 1997 ; H. Yu, B. Bianchi, R. Metzger, K. J. Lynch, E. A. Kowaluk, M. F. Jarvis, and T. van Biesen, unpublished observations).
Slow, nondesensitizing P2X currents were evoked in response to ATP application in six DRG neurons. ␣,␤-meATP (10 M) was also applied to four of these neurons, and it evoked comparable currents that did not significantly differ in amplitude or kinetics from ATP responses (Fig. 2, A and B) . These ␣,␤-meATP-induced currents in neurons had peak amplitudes of 342 Ϯ 159 pA, rise times of 119 Ϯ 23 ms, and exhibited no desensitization. For comparison, the recombinant rP2X 2/3 receptor exhibited similar ␣,␤-meATP (10 M) response kinetics to the slow DRG response (Fig. 2C) . Recombinant rP2X 2/3 -expressing cells displayed peak amplitudes of 359 Ϯ 93 pA, rise times of 73 Ϯ 23 ms, and also did not desensitize. ␣,␤-meATP was used to specifically activate P2X 2/3 receptors in all cells, because we (Bianchi et al. 1999) and others (Brake et al. 1994 ) have observed that homomeric rP2X 2 receptors are not activated by ␣,␤-meATP. These results demonstrate that the slow DRG response is not mediated by a P2X 2 receptor, but probably by a P2X 2/3 heteromeric receptor.
Approximately 70% of P2X responses in DRG neurons were desensitizing. Fast DRG responses showed fast, almost complete desensitization (Ͻ15% of peak current left at end of application) in the presence of agonist, whereas mixed DRG responses displayed fast desensitization, but did not desensitize completely (Ͼ15% of peak current left at end of application, Fig. 3, A and B) . For comparison, the recombinant rP2X 3 receptor exhibited kinetics similar to both fast and mixed DRG responses (Fig. 3C) . Responses from rP2X 3 -expressing cells activated rapidly (rise time ϭ 8.7 Ϯ 1.8 ms, n ϭ 6) to peak currents of 1089 Ϯ 254 pA. Desensitization of these receptors was best characterized by the sum of two exponential functions ( 1 ϭ 39 Ϯ 4.7, 2 ϭ 239 Ϯ 39 ms), similar to fast DRG responses. In contrast to fast DRG responses, there was a significant residual inward current left at the end of ATP application (23 Ϯ 4.7% of peak amplitude, P Ͻ 0.05, unpaired t-test), indicating that desensitization in recombinant rP2X 3 receptors was not complete. The relative ATP EC 50 values for rP2X 3 and DRG responses were 0.3 and 1.6 M (n ϭ 4), respectively.
The residual current seen at the end of ATP application to cells expressing recombinant rP2X 3 receptors prompted the question of whether or not the plateau current seen in mixed DRG responses was actually mediated by a separate nondesensitizing P2X receptor. To address this issue, the agonist sensitivity of mixed DRG responses was investigated. Both ATP and ␣,␤-meATP were equally effective in activating mixed DRG responses (Fig. 4) . In five neurons exposed to both ATP and ␣,␤-meATP, both agonists produced peak amplitudes and desensitization kinetics that were not significantly different (P Ͼ 0.05, paired t-test). The observation that both fast and slow components could be activated by both agonists indicated that either P2X 2/3 or incompletely desensitized P2X 3 receptors were involved in the slow component of the mixed DRG response. The sensitivity to ␣,␤-meATP indicated that P2X 2 receptors were not involved, because rP2X 2 receptors are insensitive to ␣,␤-meATP (Brake et al. 1994) .
Because the recombinant rP2X 3 receptor did not desensitize completely, the possibility remained that the residual current of mixed DRG responses was mediated by the same P2X 3 receptors underlying the fast component. Desensitizing P2X receptors often enter a long-lasting desensitized state following activation, whereas nondesensitizing P2X receptors do not (Bean 1990; Krishtal et al. 1983) . The activation frequency dependence of the mixed DRG response was therefore examined to determine whether or not DRG responses exhibited long-lasting desensitization. In mixed DRG neurons, decreasing the interapplication interval from 4 min to 30 s produced a selective depression of the fast peak to 22% of control, but no depression of the slow component (n ϭ 3, Fig. 5A ). Similar results were seen when either ATP or ␣,␤-meATP was used as an agonist (Fig. 7C) . In contrast, the entire waveform of fast DRG responses was depressed when application frequencies were increased (n ϭ 4, not shown). In these neurons, the peak response was depressed to 13% of control, and the plateau responses were already almost completely desensitized. Similar to fast DRG responses, the entire rP2X 3 waveform was depressed during higher frequency applications (Fig. 5B) , and responses required a 2-to 4-min interapplication interval to recover to control amplitude. Measurements taken at both peak and end of application revealed that increasing the stimulus frequency to every 15-30 s produced a depression of both peak (57 Ϯ 7% of control) and end of application amplitudes (45 Ϯ 8% of control, n ϭ 5). In contrast, the nondesensitizing rP2X 2/3 receptor could follow agonist application frequencies as fast as every 5 s without a decrease in amplitude or change in kinetics (n ϭ 3, Fig. 5C ). It is clear that mixed DRG responses have two components that show different long-lasting desensitization properties. The ability of the slow component of mixed DRG responses to follow increased application frequencies indicates the involvement of P2X 2/3 in the plateau (slow) phase.
To further differentiate the components of mixed DRG responses, the modulatory effects of extracellular protons were studied. Differential modulation of rP2X 3 and rP2X 2/3 receptors by pH has been previously demonstrated (Stoop et al. 1997) , where recombinant rP2X 3 -mediated currents were inhibited and rP2X 2/3 currents were potentiated by decreasing extracellular pH. In the present study, DRG neurons showed differential pH modulation of response amplitudes (Fig. 6A) . Fast peak amplitudes were depressed by extracellular protons (52 Ϯ 11% of control, n ϭ 4), consistent with P2X 3 receptor activation. However, the plateau (end of application) amplitude was potentiated in mixed or slow DRG neurons (189 Ϯ 15% of control, n ϭ 3). In agreement with previous reports, decreasing the extracellular pH decreased both the peak (67% of control) and end of application amplitude (68%, n ϭ 2) of recombinant rP2X 3 responses (Fig. 6B) , so that the entire waveform was depressed. In contrast, the recombinant rP2X 2/3 response was potentiated by extracellular protons (Fig. 6C) . Decreasing the pH of the agonist solution to 6.6 produced an increase in rP2X 2/3 peak amplitude to 153% of control (n ϭ 2). Acidic extracellular recording solution alone had no effect on rP2X-transfected 1321N1 cells. DRG neurons have additional proton-activated inward currents, but the amplitudes of currents elicited by acidic solution alone were Ͻ25% of the protonpotentiated P2X currents in DRG neurons (n ϭ 3). Although FIG. 5. Frequency dependence of P2X receptor activation. A: a mixed DRG response showed both fast and slow components under control conditions (stimulation every 4 min). Decreasing the interstimulus interval to every 15 s resulted in the loss of only the fast component. B: recordings from a rP2X 3 cell under control conditions (stimulation every 2 min) and after an interstimulus interval of 15 s. Note that the entire current waveform was depressed, not only the peak. C: recordings from a rP2X 2/3 cell under control conditions (stimulation every 1 min) and after an interstimulus interval of 15 s. The rP2X 2/3 receptor was able to follow short interstimulus intervals. Cells were voltage clamped at Ϫ60 mV, and agonists (10 M) were applied at the bar. FIG. 6 . pH dependence of P2X responses. A: a mixed DRG neuron responded to ␣,␤-meATP at pH 7.4 with both fast and slow desensitization kinetics. At an agonist pH of 6.6, the fast peak was decreased, but the slow plateau amplitude was increased. B: rP2X 3 responses to ␣,␤-meATP at either pH 7.4 or pH 6.6. Under acidic conditions, the entire waveform was depressed. C: rP2X 2/3 responses to ␣,␤-meATP at either pH 7.4 or pH 6.6. Under acidic conditions, the entire waveform was increased in amplitude. All cells were voltage clamped at Ϫ60 mV, and ␣,␤-meATP (10 M at the indicated pH) was applied at the bar. Cells were maintained at pH 7.4 except during 400-ms drug applications.
proton currents appeared to be activated, they were very small and their amplitude contributed only a small proportion to the entire potentiation of the plateau current. This differential modulation of fast and slow P2X components in DRG neurons suggests activation of a mixed population of both P2X 3 and P2X 2/3 receptors.
To test whether or not cutaneous afferents that innervate the rat hindpaw express P2X 3 or P2X 2/3 receptors, subplantar injections of the fluorescent tracer DiI were performed in three rats to label sensory afferents projecting to the hindpaw. Corresponding DRG neurons were then selected in culture based on DiI fluorescence. In lumbar cultures prepared from DRG ipsilateral to the injection site, one to two percent of neurons were labeled with DiI. Figure 7 shows the P2X responses of a DRG nociceptor co-labeled with DiI and IB4. This mixed DRG response exhibited both fast and slow components. The entire P2X response was blocked by TNP-ATP (100 nM, Fig. 7B ). However, increasing the agonist application frequency produced a selective inhibition of the fast component, leaving the slow component intact (Fig. 7C) . Responses from six neurons co-labeled with DiI and IB4 indicated that slow (n ϭ 1), fast (n ϭ 2), and mixed (n ϭ 3) P2X responses were present in cutaneous afferents. Based on response kinetics, TNP-ATP sensitivity and long-lasting desensitization, it appears that both P2X 3 and P2X 2/3 receptors can be expressed on these particular neurons. The subcellular distribution and physiological function of these receptor subtypes remains to be determined.
D I S C U S S I O N
The present study has shown that identified rat DRG neurons respond to P2X receptor agonists with either slow nondesensitizing kinetics, fast desensitizing kinetics, or a combination of fast and slow kinetics. The rapidly desensitizing responses were similar to P2X 3 receptor responses, and the nondesensitizing responses had properties indicative of P2X 2/3 receptor activation.
Putative P2X 3 -containing nociceptors were identified by labeling neurons in culture with fluorescent isolectin IB4 (Vulchanova et al. 1998) . Approximately 75% of neurons in culture were identified as expressing IB4 binding proteins. This is in general agreement with the percentage of IB4-labeled neurons in fixed rat DRG sections (67%) (Molliver et al. 1995) . Of the IB4-positive neurons in culture, 90% exhibited a P2X 3 or FIG. 7. Hindpaw afferents express P2X 3 and P2X 2/3 receptors. A: adult DRG neurons in culture (24 h) from a rat subjected to a hindpaw subplantar injection of DiI 10 days before DRG dissection. The same field was imaged under phase contrast illumination (patch pipette seen at bottom), standard rhodamine fluorescence (DiI staining), and standard fluorescein fluorescence (IB4 labeling). Arrows denote neuron used for recording in B and C. B: same neuron as in A, showing mixed kinetics in response to ␣,␤-meATP (control). Trinitrophenyl-ATP (TNP-ATP) was either coapplied, or preapplied for 1 min before coapplication with ␣,␤-meATP. C: same neuron as in A and B. ␣,␤-meATP was applied either every 4 min, or every 10 s. The fast component failed to follow high application frequencies. Neuron was voltage clamped at Ϫ60 mV. P2X 2/3 -like response to ATP. This relatively high percentage of cells that appear to have functional P2X 3 -containing receptors contrasts to the smaller percentage (30 -40%) of P2X 3 -positive neurons in intact DRG identified by either in situ hybridization or immunohistochemical methods (Chen et al. 1995; Vulchanova et al. 1997) . Although the reason for this is unclear, the possibility exists that the acute dissociation methods used here select for a high percentage of P2X 3 -positive neurons in culture.
P2X responses in sensory ganglia are diverse, yet it appears that P2X 2 , P2X 3 , and P2X 2/3 receptors are expressed on many sensory neurons. These receptors all function as nonspecific cation-selective channels, and most show strong inward rectification, yet they may vary in their agonist selectivity and desensitization kinetics. Trigeminal nociceptors appear to express fast P2X 3 -like receptors, as well as slow nondesensitizing P2X 2/3 -like receptors (Cook et al. 1997) . In nodose ganglia (Lewis et al. 1995; Thomas et al. 1998) , ATP responses are nondesensitizing and mediated by P2X 2 and P2X 2/3 receptors. In the DRG, early studies (Bean 1990; Jahr and Jessell 1983; Krishtal et al. 1983) reported the existence of both fast desensitizing and nondesensitizing responses to ATP. However, some of these responses may be species dependent. Amphibian DRG neurons routinely respond to ATP with nondesensitizing kinetics (Bean 1990; Li et al. 1993) , whereas the response kinetics of mammalian DRG neurons are often rapidly desensitizing. Studies using cultured neonatal rat DRG neurons (Rae et al. 1998; Robertson et al. 1996) demonstrate that these neurons respond to P2X agonists exclusively with fast kinetics. The present data confirm previous reports demonstrating that many DRG neurons show fast desensitizing kinetics and extends these observations to include other neurons that respond with either mixed or nondesensitizing kinetics. The discrepancies between the present adult DRG responses and the neonatal responses of Robertson et al. (1996) could be explained by developmental differences in P2X receptor expression, although this possibility has not been investigated.
Desensitization kinetics and agonist sensitivity are often used to broadly discriminate between P2X receptor subtypes. In this context, two distinct forms of desensitization, acute and long-lasting, were examined. Acute desensitization refers to the decrease in response amplitude in the presence of agonist, and long-lasting desensitization refers to the decrease in amplitude of the second of a pair of responses. In the latter case, channels have entered a desensitized state from which they cannot be activated for periods of up to minutes. While the rP2X 3 receptor responds to both ATP and ␣,␤-meATP with fast acute desensitization kinetics, the rP2X 2 receptor is insensitive to ␣,␤-meATP and responds to ATP with nondesensitizing kinetics (Brake et al. 1994; Chen et al. 1995) . The rP2X 2/3 receptor has a novel profile, being ␣,␤-meATP-sensitive, yet having nondesensitizing kinetics (Lewis et al. 1995) . The present study found that both rP2X 3 and fast DRG responses were activated by either ATP or ␣,␤-meATP, displayed biphasic acute desensitization kinetics, and required prolonged interapplication intervals (minutes) to recover from long-lasting desensitization. Although the responses always desensitized in the presence of agonist, acute desensitization was not always complete, and a plateau current was often present at the end of the application. Shorter interapplication intervals produced a subsequent depression of the entire rP2X 3 or fast DRG waveform, not just the peak. Similarly, both rP2X 2/3 and slow DRG responses were activated by either ATP or ␣,␤-meATP. However, there was no acute desensitization, and responses could easily follow interapplication intervals as fast as 5 s without a decrease in response amplitude. The differences in long-lasting desensitization were used as discriminators when interpreting the receptor subtypes underlying mixed DRG responses. Applications of either ATP or ␣,␤-meATP elicited mixed DRG responses characterized by both fast and slow response kinetics. When short interapplication intervals were used, only the fast peak of mixed DRG responses was depressed, and the slow plateau amplitude was left unaffected. This response profile indicates activation of P2X 3 in the fast phase, and P2X 2/3 receptors in the slow plateau phase.
The fast DRG components responded to all pharmacological manipulations similarly to rP2X 3 receptor responses. ATP and ␣,␤-meATP were relatively equipotent at eliciting this response. The fast response was also blocked by the nonspecific P2X receptor antagonist suramin, as well as the more selective antagonist TNP-ATP. At nanomolar concentrations, TNP-ATP has been shown to be a selective antagonist for P2X 1 , P2X 3 , and P2X 2/3 receptors ). The entire waveform of the fast DRG response was also depressed by lowering external pH, an effect attributed to proton modulation of the P2X 3 receptor (Stoop et al. 1997 ). Interestingly, P2X 1 receptors also share this pharmacological profile. However, previous results based on selectivity of ␤,␥-meATP isomers have indicated that fast DRG responses are P2X 3 , and not P2X 1 mediated (Rae et al. 1998) . The pharmacological similarities between fast DRG responses in the present study and those of Rae et al. (1998) also implicate the involvement of P2X 3 receptors.
The fact that both ATP and ␣,␤-meATP elicited slow DRG responses implicates P2X 2/3 , and not P2X 2 , receptor activation. Although the present study did not specifically address the existence of P2X 2 homomeric receptors, a consistent observation was that comparable slow DRG currents were elicited by either agonist in the same neuron, indicating that homomeric P2X 2 receptors were not activated. The P2X antagonist TNP-ATP is relatively insensitive at P2X 2 receptors, yet it completely blocked slow DRG responses, consistent with a preferential expression of P2X 2/3 over P2X 2 . The slow component of mixed DRG responses was increased in amplitude under acidic extracellular conditions and could follow short interapplication intervals. These effects are opposite to those seen with fast DRG responses under identical conditions, further emphasizing that fast and slow components of mixed DRG responses are mediated by separate P2X receptors.
The precise role of P2X receptors on nociceptive afferents is not known. However, increasing evidence supports the idea that P2X receptors can increase sensory neuron excitability. Subplantar administration of ␣,␤-meATP produces a nociceptive response in rats (Bland-Ward and Humphrey 1997), consistent with functional involvement of P2X receptors in the periphery (Cook et al. 1997) . Gu and MacDermott (1997) have demonstrated that presynaptic P2X receptors located on DRG terminals can increase glutamatergic neurotransmission at DRG-dorsal horn synapses in culture. Similar results have been obtained from recordings in brain stem slices (Khakh and Henderson 1998) . A presynaptic facilitatory role for P2X receptors at central dorsal horn synapses could enhance neurotransmission, leading to an increase in pain sensation. The present study has demonstrated that two P2X receptors could mediate this effect, a fast, transient P2X 3 receptor as well as a slow, sustained P2X 2/3 receptor. The purpose of each receptor subtype in this pathway remains unknown, but it appears that there exist two distinct P2 receptor subtypes at which pharmacological agents could potentially be targeted for the treatment of pain.
